Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on cardiovascular events in patients with heart failure: a meta-analysis of randomized controlled trials

Controlled Trials ◽

Angiotensin Ii Receptor ◽

Randomized Controlled ◽

Patients With Heart Failure ◽

Safety of the Combination of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients with Heart Failure: A Systematic Review and Meta Analysis of Randomized Controlled Trials

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2006.06.248 ◽

2006 ◽

Vol 12 (6) ◽

pp. S73

Author(s):

Rachid Lakhdar ◽

Mouaz H. Al-Mallah

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Patients With Heart Failure ◽

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CARDIOVASCULAR RISK FACTORS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(15)61423-1 ◽

2015 ◽

Vol 65 (10) ◽

pp. A1423

Author(s):

Vu Linh Hoang ◽

Daniel Addison ◽

Don Pham ◽

Mahboob Alam ◽

Yochai Birnbaum

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

New Approaches to Blockade of the Renin–Angiotensin–Aldosterone System: Evidence From Randomized Controlled Trials (RCTs) of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Blockers — Questions Remain Unsolved

Journal of Pharmacological Sciences ◽

10.1254/jphs.10r08fm ◽

2010 ◽

Vol 113 (4) ◽

pp. 292-295 ◽

Cited By ~ 6

Author(s):

Shinichiro Ueda

Keyword(s):

Angiotensin Ii ◽

Angiotensin Converting Enzyme ◽

Enzyme Inhibitors ◽

Controlled Trials ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Randomized Controlled ◽

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS & ANGIOTENSIN RECEPTOR BLOCKERS ON RISK OF MORTALITY: A META-ANALYSIS OF RANDOMIZED-CONTROLLED TRIALS INVOLVING 317,984 PATIENTS

Journal of Hypertension ◽

10.1097/01.hjh.0000746700.43368.89 ◽

2021 ◽

Vol 39 (Supplement 1) ◽

pp. e200-e201

Author(s):

Manal Alosaimi ◽

Nur Aishah Che Roos ◽

Anwar Mansour Alnakhli ◽

John G.F. Cleland ◽

Sandosh Padmanabhan

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Risk Of Mortality ◽

Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: A meta-analysis of randomized controlled trials

Clinical Nephrology ◽

10.5414/cn109193 ◽

2018 ◽

Vol 89 (6) ◽

pp. 445-454 ◽

Cited By ~ 2

Author(s):

Yue Yang ◽

Ye-ping Ma ◽

Zheng Zhang ◽

Pei-lin Dai ◽

Ping Li ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Converting Enzyme ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-016-6652-7 ◽

2016 ◽

Vol 30 (2) ◽

pp. 189-198 ◽

Cited By ~ 5

Author(s):

Vu Hoang ◽

Mahboob Alam ◽

Daniel Addison ◽

Francisco Macedo ◽

Salim Virani ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease

Erratum to: Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials

Cardiovascular Drugs and Therapy ◽

10.1007/s10557-016-6657-2 ◽

2016 ◽

Vol 30 (2) ◽

pp. 199-199

Author(s):

Vu Hoang ◽

Mahboob Alam ◽

Daniel Addison ◽

Francisco Macedo ◽

Salim Virani ◽

...

Keyword(s):

Enzyme Inhibitors ◽

Meta Analysis ◽

Controlled Trials ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease

Angiotensin converting enzyme inhibitors and angiotensin II receptor blockers and outcomes in patients with acute decompensated heart failure: a systematic review and meta-analysis

Expert Review of Cardiovascular Therapy ◽

10.1080/14779072.2021.2004121 ◽

2021 ◽

Author(s):

Jerald Pelayo ◽

Kevin Bryan Lo ◽

Eric Peterson ◽

Carly DeFaria ◽

Atif Nehvi ◽

...

Keyword(s):

Heart Failure ◽

Enzyme Inhibitors ◽

Acute Decompensated Heart Failure ◽

Meta Analysis ◽

Decompensated Heart Failure ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers and Diabetes: A Meta-Analysis of Placebo-Controlled Clinical Trials

American Journal of Hypertension ◽

10.1038/ajh.2011.8 ◽

2011 ◽

Vol 24 (5) ◽

pp. 582-590 ◽

Cited By ~ 48

Author(s):

G. Tocci ◽

F. Paneni ◽

F. Palano ◽

S. Sciarretta ◽

A. Ferrucci ◽

...

Keyword(s):

Clinical Trials ◽

Angiotensin Ii ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Converting Enzyme ◽

Angiotensin Ii Receptor ◽

Controlled Clinical Trials ◽

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CORONARY ARTERY DISEASE AND NO CLINICAL EVIDENCE OF HEART FAILURE: A META-ANALYSIS OF RANDOMIZED-CONTROLLED TRIALS

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(14)61428-5 ◽

2014 ◽

Vol 63 (12) ◽

pp. A1428

Author(s):

Vu Linh Hoang ◽

Daniel Addison ◽

Yochai Birnbaum ◽

Francisco Macedo ◽

Mahboob Alam

Keyword(s):

Clinical Evidence ◽

Enzyme Inhibitors ◽

Meta Analysis ◽

Angiotensin Receptor ◽

Randomized Controlled ◽

Receptor Blockers ◽

Artery Disease